ATOSSA GENETICS INC NASDAQ:​ATOS

Atossa Genetics Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, yesterday FDA Aprroved Oral Endoxifen for breast cancer patient. Endoxifen is an active metabolite of tamoxifen, which is an FDA-approved drug to prevent new as well as recurrent disease in breast...

ATOS is making a double bottom and is about to break out soon.

$10 target is picked because thats where 200 SMA is at.

description on chart.

ATOS gapped up this morning due to news of their FDA approval. The float is low at 5.47M and a marketcap of 38.67M. We will be watching this stock tomorrow for continuation trades. You can watch my full video review for $ATOS by using the link in my signature description!

who doesnt like generic epi pens …. current level and under seem legit enough for the risk.

look for a long after breaking of trend and pull back to the level it broke up, if this level holds should be good indication of going up to the next levels.

low risk, high reward set up

Don't have time to lay out the details. Recent squeeze, warrants didnt get exercised either. Chance that this next squeeze will follow through with an offering SHORT TERM TRADE

Yesturday marked a possible buy signal. The price action is making newer lows, while the MACD is making higher highs, this marks a bullish divergence. Tomorrow should be the confirmation of this signal, if and only if this it closes higher than todays close.

(ATOS)

Read Chart Descriptions!

This should finish up the 2nd leg of the cycle next week and might be a good investment at that time. I like the way the waves are so clearly defined.

The pennant pattern is starting to tighten, look for ATOS to test top trendline. If it breaks, could trend upwards to test first price target. The stop loss is set in the case it breaks the pattern.

AS THE CHART SHOWS. IT MIGHT BE THE SAME PATTERN.

ATOS has been trading sideways for the better part of a month showing little move in volume and no strong RSI pull to the bullish or bearish side. Recently it has exhibited an increase in volume that may be due to the recent arrival of their new scientific advisor Dr. Cal Novina. Moreover, on the 15th of November (Marked with an arrow) the CFO of the company, Guse...

in the weekly time frame we can see the 5 wave down trend completed and in the wave 5 we have ending diagonal with increase volume that show new up trend should be start soon, after break out the last minor peak we can open buy position and enjoy our profits

Low float, act in range and breaking out right now.